Key Takeaways:
Tradr ETFs will introduce two first-to-market single-stock inverse ETFs on Thursday, April 23, offering investors a way to pursue a bearish strategy on Lumentum Holdings Inc. (LITE) and Sandisk Corp. (SNDK). The new funds, listed on the Cboe, are designed to deliver two times the inverse of the daily returns of the underlying stocks, a move that could increase trading volatility in both names.
"Tradr ETFs are designed for sophisticated investors and professional traders who are looking to express high conviction investment views," the company stated in its press release.
The two new funds are the Tradr 2X Short LITE Daily ETF (Cboe: LITZ) and the Tradr 2X Short SNDK Daily ETF (Cboe: SNDQ). These products are part of a growing market of leveraged and inverse ETFs that provide short or long exposure to individual stocks. The use of leverage means these funds are riskier than traditional ETFs, as they magnify the performance of the underlying security. For example, a 50% adverse move in the underlying stock on a single day could result in a total loss of investment.
The launch of these inverse ETFs provides a new tool for traders to bet against Lumentum and Sandisk, potentially creating downward pressure on their stock prices. For existing shareholders, these instruments could also serve as a hedging mechanism against short-term declines. However, the issuer, Tradr ETFs, warns that these are intended for short-term trading by sophisticated investors who understand the risks of leverage and shorting.
The introduction of these leveraged financial products comes with a strong caution from the issuer. Tradr ETFs emphasizes that the funds are intended for active traders who can monitor their investments closely. The firm's website and the funds' prospectus contain detailed information on the significant risks involved.
Leveraged ETFs are designed to achieve their stated objectives on a daily basis. Over longer periods, the performance of these funds can differ significantly from the underlying stock's performance. This is due to the compounding effect of daily returns, which can cause the fund's performance to diverge from the benchmark's performance, especially in volatile markets.
Investors are strongly encouraged to read the prospectus carefully before investing. The document outlines the investment objectives, risks, charges, and expenses of the funds. As with all ETFs, shares are bought and sold at market price and are not individually redeemed from the fund.
This article is for informational purposes only and does not constitute investment advice.
